Stockscreener 앱 받기
22.74
6.23%
-1.51
시간 외 거래:
22.71
-0.03
-0.13%
전일 마감가:
$24.25
열려 있는:
$23.12
하루 거래량:
3.24M
Relative Volume:
1.22
시가총액:
$2.30B
수익:
$352.57M
순이익/손실:
$-143.01M
주가수익비율:
-12.56
EPS:
-1.81
순현금흐름:
$-153.40M
1주 성능:
-13.96%
1개월 성능:
-11.69%
6개월 성능:
+12.35%
1년 성능:
-6.65%
1일 변동 폭
$22.58
$23.95
1주일 범위
$22.58
$26.40
52주 변동 폭
$13.53
$35.25
빔 테라퓨틱스 Stock (BEAM) Company Profile
명칭
Beam Therapeutics Inc
전화
857-327-8775
주소
26 LANDSDOWNE STREET, CAMBRIDGE, MA
BEAM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAM
Beam Therapeutics Inc
|
22.74 | 2.45B | 352.57M | -143.01M | -153.40M | -1.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
빔 테라퓨틱스 Stock (BEAM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-09 | 개시 | Jefferies | Buy |
| 2025-03-28 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-03-10 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-01-29 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-23 | 개시 | H.C. Wainwright | Buy |
| 2024-01-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-10-20 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-10-20 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-03-21 | 개시 | Bernstein | Mkt Perform |
| 2023-02-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-20 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2022-12-13 | 개시 | Citigroup | Buy |
| 2022-06-17 | 개시 | BMO Capital Markets | Market Perform |
| 2022-04-28 | 개시 | Credit Suisse | Neutral |
| 2022-01-05 | 개시 | Guggenheim | Buy |
| 2021-10-19 | 개시 | SVB Leerink | Outperform |
| 2021-09-24 | 재개 | Stifel | Buy |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-05-11 | 개시 | Redburn | Buy |
| 2021-05-04 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-03-01 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-02-16 | 개시 | Wells Fargo | Overweight |
| 2021-01-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-01-06 | 개시 | Stifel | Hold |
| 2020-08-05 | 개시 | William Blair | Outperform |
| 2020-03-02 | 개시 | Barclays | Overweight |
| 2020-03-02 | 개시 | JP Morgan | Overweight |
| 2020-03-02 | 개시 | Jefferies | Buy |
| 2020-03-02 | 개시 | Wedbush | Outperform |
모두보기
빔 테라퓨틱스 주식(BEAM)의 최신 뉴스
Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com
Beam (BEAM) Advances Clinical Programs in Genetic Disease Base E - GuruFocus
Beam Therapeutics Q3 2025 Earnings: EPS Misses at -$1.10, Revenue Falls Short at $9.7 Million - GuruFocus
Earnings Flash (BEAM) Beam Therapeutics Inc. Reports Q3 Revenue $9.7M, vs. FactSet Est of $11.3M - MarketScreener
Beam Therapeutics Q3 net loss wider than expected on higher R&D expenses - MarketScreener
Visualizing Beam Therapeutics Inc. stock with heatmapsBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Beam Therapeutics Inc. SEC 10-Q Report - TradingView
Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates - The Manila Times
Oculis (NASDAQ: OCS) and EURETINA honor Prithvi Ramtohul, 2025 Ramin Tadayoni Awardee - Stock Titan
Analyzing drawdowns of Beam Therapeutics Inc. with statistical tools2025 Risk Factors & Intraday High Probability Alerts - newser.com
How Beam Therapeutics Inc. stock compares to market leadersWeekly Gains Report & Risk Controlled Stock Pick Alerts - newser.com
Beam Therapeutics Stock Faces Pivotal Week with Key Catalysts Ahead - AD HOC NEWS
ARK Investment Acquires Significant Stake in Beam Therapeutics ( - GuruFocus
Beam to present updated data on sickle cell gene therapy at ASH meeting - Investing.com
ASH 2025: Beam Therapeutics (NASDAQ: BEAM) to share updated BEAM-101 sickle cell data - Stock Titan
Why retail investors favor Beam Therapeutics Inc. stockTrade Performance Summary & Long-Term Capital Growth Ideas - newser.com
How buybacks impact Beam Therapeutics Inc. stock value2025 Trading Recap & AI Enhanced Trading Signals - newser.com
Historical volatility pattern of Beam Therapeutics Inc. visualizedStop Loss & Proven Capital Preservation Tips - newser.com
Institutional scanner results for Beam Therapeutics Inc.Market Rally & Fast Exit Strategy with Risk Control - newser.com
AMG National Trust Bank Buys Shares of 17,007 Beam Therapeutics Inc. $BEAM - MarketBeat
What is the fair value of Beam Therapeutics Inc. stock nowWeekly Trend Summary & Community Consensus Stock Picks - newser.com
Visual analytics tools that track Beam Therapeutics Inc. performanceMarket Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
Why Beam Therapeutics Inc. stock is favored by pension fundsJuly 2025 Sentiment & Fast Momentum Entry Tips - newser.com
What analyst consensus says on Beam Therapeutics Inc. stock2025 Top Gainers & Daily Volume Surge Signals - newser.com
Real time social sentiment graph for Beam Therapeutics Inc.2025 Market Overview & Expert Curated Trade Ideas - newser.com
How to monitor Beam Therapeutics Inc. with trend dashboardsStop Loss & High Accuracy Trade Signal Alerts - newser.com
Published on: 2025-11-02 01:58:11 - newser.com
Will Beam Therapeutics Inc. stock deliver long term returnsPortfolio Profit Report & Weekly Top Performers Watchlists - newser.com
Should you wait for a breakout in Beam Therapeutics Inc.Sell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Beam Therapeutics Inc. stock outperform Nasdaq indexInsider Buying & Stepwise Trade Signal Guides - newser.com
What hedge fund activity signals for Beam Therapeutics Inc. stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Published on: 2025-10-31 03:50:40 - newser.com
ETFs Investing in Beam Therapeutics Inc. Stocks - TradingView
Why retail investors pile into Beam Therapeutics Inc. stockTreasury Yields & Real-Time Volume Triggers - newser.com
Beam Therapeutics Inc. (BEAM) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
빔 테라퓨틱스 (BEAM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):